Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Context Therapeutics Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q1 2023
- Shares held
- 2.24M
- +952.0K (+74.0%) vs. Q1 2023
- Total value
- $3.58M
- +$2.86M (+395.7%) vs. Q1 2023
- New holders
- 5
- 4 more added
- Sold out
- 5
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $34.8M |
| Q1 2026 | 60 | $194.6M |
| Q4 2025 | 43 | $96.0M |
| Q3 2025 | 37 | $66.8M |
| Q2 2025 | 39 | $45.0M |
| Q1 2025 | 42 | $43.7M |
| Q4 2024 | 52 | $76.4M |
| Q3 2024 | 42 | $111.2M |
| Q2 2024 | 34 | $114.3M |
| Q1 2024 | 25 | $5.43M |
| Q4 2023 | 24 | $4.02M |
| Q3 2023 | 23 | $3.89M |
| Q2 2023 | 22 | $3.58M |
| Q1 2023 | 22 | $722.6K |
| Q4 2022 | 24 | $2.55M |
| Q3 2022 | 24 | $4.59M |
| Q2 2022 | 20 | $6.32M |
| Q1 2022 | 16 | $6.30M |
| Q4 2021 | 19 | $9.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ally Bridge Group (NY) LLC | 653,396 | $1.05M | 1.27% | +653,396 | New |
| Vanguard Group Inc | 574,700 | $919.5K | 0.00% | +1,300+0.2% | Added |
| Affinity Asset Advisors, LLC | 267,574 | $428.1K | 0.17% | +267,574 | New |
| HighTower Advisors, LLC | 125,852 | $201.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 107,234 | $171.6K | 0.00% | +47,666+80.0% | Added |
| Bridgeway Capital Management, LLC | 105,809 | $169.3K | 0.00% | 00.0% | Unchanged |
| Mill Creek Capital Advisors, LLC | 104,631 | $167.4K | 0.01% | 00.0% | Unchanged |
| UBS Oconnor LLC | 65,628 | $105.0K | 0.00% | +65,628 | New |
| Northern Trust Corp | 37,219 | $59.5K | 0.00% | 00.0% | Unchanged |
| Clear Harbor Asset Management, LLC | 36,000 | $57.6K | 0.01% | +36,000 | New |
| Difesa Capital Management, LP | 34,878 | $55.8K | 0.15% | 00.0% | Unchanged |
| State Street Corp | 32,907 | $52.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 28,300 | $45.0K | 0.00% | +9,100+47.4% | Added |
| Two Sigma Investments, LP | 26,839 | $42.9K | 0.00% | −28,849−51.8% | Reduced |
| Sheets Smith Wealth Management | 20,000 | $32.0K | 0.00% | 00.0% | Unchanged |
| Aspire Wealth Management Corp | 10,000 | $16.0K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,937 | $9.50K | 0.00% | −2,906−32.9% | Reduced |
| Advisor Group Holdings, Inc. | 1,500 | $2.40K | 0.00% | +1,500 | New |
| Federation des caisses Desjardins du Quebec | 400 | $640 | 0.00% | 00.0% | Unchanged |
| Retirement Group, LLC | 155 | $248 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 107 | $171 | 0.00% | +4+3.9% | Added |
| Bank of America Corp | 100 | $160 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −41,191−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −24,599−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −10,651−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −5,767−100.0% | Sold out |